Recurrent vulvovaginal candidiasis: Current management

Australian Family Physician

Volumn 40, Issue 3, 2011, Pages 149-151

  Watson, Cathy ^a   Pirotta, Marie ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Candidiasis; Practice guidelines as topic; Questionnaires; Recurrence; Treatment failure; Vulvovaginal

Indexed keywords

ANTIFUNGAL AGENT;

ARTICLE; AUSTRALIA AND NEW ZEALAND; CLINICAL PRACTICE; FEMALE; HUMAN; PRACTICE GUIDELINE; RECURRENT DISEASE; VAGINA CANDIDIASIS;

ANTIFUNGAL AGENTS; AUSTRALASIA; CANDIDIASIS, VULVOVAGINAL; FEMALE; GUIDELINE ADHERENCE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; RECURRENCE;

EID: 79952668045     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Nyirjesy P. Vulvovaginal candidiasis and bacterial vaginosis. Infect Dis Clin North Am 2008;22:637-52.
2. Sobel JD. Vulvovaginal candidosis. Lancet 2007;369:1961-71.
3. Therapeutic Guidelines Limited. Genital (reproductive) tract infections. West Melbourne: Therapeutic Guidelines, 2006. Available at http://proxy9.use.hcn.com.au.
4. Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis. Update by the Infectious Diseases Society of America. Clin Infect Dis 2009;48:503-35.
5. Sobel JD, Wiesenfeld HC, Martens M, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med 2004;351:876-83.
6. Donders GG, Bellen G, Byttebier G, et al. Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial). Am J Obstet Gynecol 2008;199:613e.1-9.
7. Singh S, Sobel JD, Bhargava P, et al. Vaginitis due to Candida krusei: epidemiology, clinical aspects, and therapy. Clin Infect Dis 2002;35:1066-70.